SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Rock-Star Investors Next Door
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

1 pt

Bookkeeping: Limit Order for China Medical (CMED) Hit Yesterday

 Aug 08, 2008 01:29 PM UTC
Tradermark
Return Risk
-12.43% LOW
Analyst
Symbol Sentiment Start Return Closed
CMED Positive 08/08/08 -13.35% 08/28/08

Graphic_arrow1 Via Fund my Mutual Fund:  

I highlighted the excellent China Medical (CMED) earnings Tuesday premarket [Aug 5: China Medical - Back on Track; Valuation Should be Higher] and was not at the computer most of Tuesday so missed the move up; Wednesday morning the stock was up 18% from where I had pointed it out so instead of chasing I wrote

I'll stick a limit order at the top of this gap and see if we can snag it on an inevitable pullback.

So instead of chasing it up in the $53s, or $54 - I placed a 300 limit share order @ $50.50 which hit late yesterday. I added another 100 shares this AM in a similar price level. Therefore China Medical is now a 1.9% stake in the fund as we continue to change the focus of our holdings. As you know healthcare (and airlines) are the new fertilizer. I'd like to add to this position in the mid $40s. It remains dirt cheap, even at $60+.

Long China Medical in fund...




Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 19.61 +43.19% 176
2 18.26 +42.29% 57
3 16.35 +17.71% 7
4 14.95 +39.54% 212
5 13.77 +16.71% 40


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
China Medical Technologies Inc ADS (CMED)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
94.0%
Top:
100.0%




TODAY'S HEADLINES





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch